Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Aims to help researchers make better use of scarce tissue and cell materials often used in cancer and disease studies.
February 18, 2026
By: Charlie Sternberg
Associate Editor
Thermo Fisher Scientific has introduced a laboratory kit designed to extract protein, DNA and RNA from a single biological sample, aiming to help researchers make better use of scarce tissue and cell materials often used in cancer and disease studies.
The Thermo Scientific Sequential Protein/DNA/RNA Extraction Kit allows scientists to generate proteomic and genomic data from the same specimen, reducing the need to divide small or difficult‑to‑replace samples. The company says the approach supports studies that seek to link genetic variation, gene expression and protein activity—analyses typically carried out in separate workflows.
According to Thermo Fisher, the kit yields protein suitable for mass‑spectrometry analysis and nucleic acids compatible with next‑generation sequencing. The magnetic‑bead workflow also enables automation and eliminates centrifugation steps.
Researchers who rely on limited materials, such as biopsies or rare cell populations, are the primary intended users. Malin Karlsson, a senior director in Thermo Fisher’s Life Sciences Solutions Group, said the new kit helps scientists “make the most” of samples collected through invasive or one‑time procedures.
Thermo Fisher is positioning the kit for cancer and disease biology research where connecting molecular signals across multiple layers is essential, and where sample scarcity often limits the scope of analysis.
Thermo Fisher Scientific recently announced it will close a manufacturing facility in Franklin, Massachusetts as it continues to pare its manufacturing footprint.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !